Approximately 50% to 60% of amyotrophic lateral sclerosis (ALS) is characterized by an increase in metabolic rate. The Harris and Benedict (HB) 1919 formula is the equation mainly used to calculate resting energy expenditure (cREE) compared with measured REE (mREE) by indirect calorimetry (IC), but other formulas are also applied in current practice.
The present study aimed to assess mREE in patients with ALS compared with 12 cREE formulas and study the relevant threshold of REE variation to screen patients with a higher evolving risk.Nutritional assessments and body composition (by bioimpedance analysis) were performed in patients with ALS.
mREE was measured by IC, and cREE was calculated using the HB 1919, HB 1984, World Schofield, De Lorenzo, Johnstone, Mifflin, World Health Organization/FoodandAgricultureOrganization, Owen, Fleisch, Wang, Rosenbaum, and Nelson formulas.
Functional and respiratory evolution and survival by log-rank test according to two thresholds of REE variation (10% and 20%) were studied.A total of 315 patients with ALS were included in the study. The median mREE was 1503 kcal/24 h (range, 1290-1698 kcal/24 h), which was higher than all predictive equations (P < 0.0001). Depending on the predictive equation, REE variation >10% and 20% was found in 35.2% to 76.3% and 14.6% to 53.3% of patients with ALS, respectively.
Patients with an REE variation >20% with HB 1919 and HB 1984 had a lower survival. Moreover, with this same threshold and the Mifflin formula, patients had higher functional and respiratory evolutions and lower survival.The increase in metabolic rate is present according to the different cREE formulas used compared with IC.
In clinical practice, REE formulas (e.g., HB 1919, HB 1984, or Mifflin) can be used as a reference value compared with IC to screen patients with ALS with an REE variation >20% and a higher evolving risk.
Compound FL0097 |
|||
FL0097-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Compound FL0097 |
Julabo FL1201 Chiller |
|||
BAT2504 | Scientific Laboratory Supplies | EACH | EUR 8025.6 |
FL-411 |
|||
HY-111102 | MedChemExpress | 25mg | EUR 1575.6 |
FL411 |
|||
462472 | MedKoo Biosciences | 25.0mg | EUR 450 |
FL-411 |
|||
T4365-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: FL-411 |
FL-411 |
|||
T4365-1g | TargetMol Chemicals | 1g | Ask for price |
Description: FL-411 |
FL-411 |
|||
T4365-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: FL-411 |
FL-411 |
|||
T4365-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: FL-411 |
FL-411 |
|||
T4365-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: FL-411 |
FL104 |
|||
T27328-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: FL104 |
FL104 |
|||
T27328-1g | TargetMol Chemicals | 1g | Ask for price |
Description: FL104 |
FL104 |
|||
T27328-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: FL104 |
FL104 |
|||
T27328-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: FL104 |
FL104 |
|||
T27328-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: FL104 |
FL118 |
|||
T27329-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: FL118 |
FL118 |
|||
T27329-1g | TargetMol Chemicals | 1g | Ask for price |
Description: FL118 |
FL118 |
|||
T27329-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: FL118 |
FL118 |
|||
T27329-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: FL118 |
FL118 |
|||
T27329-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: FL118 |
(R)-FL-118 |
|||
F401290 | Toronto Research Chemicals | 25mg | EUR 23000 |
Description: 151636-76-9 |
Julabo FL300 Chiller |
|||
BAT2500 | Scientific Laboratory Supplies | EACH | EUR 4700.4 |
Julabo FL601 Chiller |
|||
BAT2502 | Scientific Laboratory Supplies | EACH | EUR 6319.2 |
Human IL-37(1F7/F1L1ζ) ELISA kit |
|||
E22-HC116.48 | EnoGene | 48T | EUR 295 |
Human IL-37(1F7/F1L1ζ) ELISA kit |
|||
E22-HC116.96 | EnoGene | 96T | EUR 395 |
F630111L10Rik (Mouse) - 3 unique 27mer siRNA duplexes - 2 nmol each |
|||
SR401571 | Origene Technologies GmbH | 2 nmol | Ask for price |
Anti-ORF1 FL49 (4E11) |
|||
YF-MA19548 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to ORF1 FL49 |
Human IL-37/IL1F7/F1L1Z ELISA Kit |
|||
RK00117 | Abclonal | 96 Tests | EUR 625.2 |
Gilson PIPETMAN L Fixed F5000L 5000ul |
|||
FA10031 | Scientific Laboratory Supplies | EACH | EUR 256.8 |
FL3 |
|||
T27330-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: FL3 |
FL3 |
|||
T27330-1g | TargetMol Chemicals | 1g | Ask for price |
Description: FL3 |
FL3 |
|||
T27330-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: FL3 |
FL3 |
|||
T27330-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: FL3 |
FL3 |
|||
T27330-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: FL3 |
N-Des(4-Fluorophenyl)-N-(3-fluorophenyl) Ezetimibe |
|||
D292325 | Toronto Research Chemicals | 100mg | EUR 227 |
Description: 1700622-06-5 |
4-Fluoro-delta-(4-fluorophenyl)benzenebutanol |
|||
F591810 | Toronto Research Chemicals | 2.5g | EUR 3000 |
Description: 50337-85-4 |
3-(3-Fluorobenzyl)-4-[(3-fluorobenzyl)oxy]benzaldehyde |
|||
F597935 | Toronto Research Chemicals | 10mg | EUR 345 |
Description: 1000370-24-0 |
3-(2-Fluorobenzyl)-4-[(2-fluorobenzyl)oxy]benzaldehyde |
|||
F597955 | Toronto Research Chemicals | 500mg | EUR 800 |
Description: 1000370-25-1 |
N-Des(4-Fluorophenyl)-N-(3-Fluorophenyl)-Ezetimibe-d4 |
|||
D292327 | Toronto Research Chemicals | 50mg | EUR 7600 |
1-(4-Fluorophenyl)-N-[(4-fluorophenyl)methyl]methanimine |
|||
F632245 | Toronto Research Chemicals | 250mg | EUR 1200 |
Description: 428819-12-9 |
3-Des-(4-fluorophenyl) 3-(4-Fluorobiphen-3-yl) Aprepitant |
|||
D228795 | Toronto Research Chemicals | 75mg | EUR 12800 |
5-fluoro 203 |
|||
C4114-10 | ApexBio | 10 mg | EUR 289.2 |
Description: 5-fluoro 203 (5F-203) is an antitumor agent and cytotoxic compound that acts as a potent AhR agonist [1][2][3]. The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor involved in regulating xenobiotic-metabolizing enzymes such as cytochrome P450. |
5-fluoro 203 |
|||
C4114-25 | ApexBio | 25 mg | EUR 582 |
Description: 5-fluoro 203 (5F-203) is an antitumor agent and cytotoxic compound that acts as a potent AhR agonist [1][2][3]. The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor involved in regulating xenobiotic-metabolizing enzymes such as cytochrome P450. |
5-fluoro 203 |
|||
C4114-5 | ApexBio | 5 mg | EUR 184.8 |
Description: 5-fluoro 203 (5F-203) is an antitumor agent and cytotoxic compound that acts as a potent AhR agonist [1][2][3]. The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor involved in regulating xenobiotic-metabolizing enzymes such as cytochrome P450. |
5-fluoro 203 |
|||
T21704-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: 5-fluoro 203 |
5-fluoro 203 |
|||
T21704-1g | TargetMol Chemicals | 1g | Ask for price |
Description: 5-fluoro 203 |
5-fluoro 203 |
|||
T21704-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: 5-fluoro 203 |
5-fluoro 203 |
|||
T21704-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: 5-fluoro 203 |
5-fluoro 203 |
|||
T21704-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: 5-fluoro 203 |
5-Fluoro-2-(4-fluorophenyl)-4-(trifluoromethyl)-1,3-oxazole |
|||
F601165 | Toronto Research Chemicals | 100mg | EUR 1200 |
Description: 83081-29-2 |
5-Fluoro ADB |
|||
F587245 | Toronto Research Chemicals | 10mg | EUR 158 |
Description: 1971007-89-2 |
4-Fluoro-5-(2-fluorophenyl)-1H-pyrrole-3-carboxaldehyde |
|||
F428220 | Toronto Research Chemicals | 500mg | EUR 800 |
Description: 928324-57-6 |
(S)-2-[[3-(3-Fluorobenzyl)-4-[(3-fluorobenzyl)oxy]benzyl]amino]propanamide |
|||
F590975 | Toronto Research Chemicals | 10mg | EUR 775 |
Description: 1000370-27-3 |
pCDNA3.1-FLAG(-) |
|||
PVT18203 | Lifescience Market | 2 ug | EUR 309.6 |
5-fluoro AMT HCl |
|||
463460 | MedKoo Biosciences | 1.0mg | EUR 350 |
5-Fluoro NNEI |
|||
F588720 | Toronto Research Chemicals | 10mg | EUR 759 |
Description: 1445580-60-8 |
4-fluoro-N-(3-fluoro-4-methylphenyl)-3-{[(4-methoxyphenyl)methyl |
|||
T50103-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: 4-fluoro-N-(3-fluoro-4-methylphenyl)-3-{[(4-methoxyphenyl)methyl]sulfamoyl}benzamide |
4-fluoro-N-(3-fluoro-4-methylphenyl)-3-{[(4-methoxyphenyl)methyl |
|||
T50103-1g | TargetMol Chemicals | 1g | Ask for price |
Description: 4-fluoro-N-(3-fluoro-4-methylphenyl)-3-{[(4-methoxyphenyl)methyl]sulfamoyl}benzamide |
4-fluoro-N-(3-fluoro-4-methylphenyl)-3-{[(4-methoxyphenyl)methyl |
|||
T50103-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: 4-fluoro-N-(3-fluoro-4-methylphenyl)-3-{[(4-methoxyphenyl)methyl]sulfamoyl}benzamide |
4-fluoro-N-(3-fluoro-4-methylphenyl)-3-{[(4-methoxyphenyl)methyl |
|||
T50103-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: 4-fluoro-N-(3-fluoro-4-methylphenyl)-3-{[(4-methoxyphenyl)methyl]sulfamoyl}benzamide |
4-fluoro-N-(3-fluoro-4-methylphenyl)-3-{[(4-methoxyphenyl)methyl |
|||
T50103-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: 4-fluoro-N-(3-fluoro-4-methylphenyl)-3-{[(4-methoxyphenyl)methyl]sulfamoyl}benzamide |
9-Fluorenol 95% |
|||
F01640 | Pfaltz & Bauer | 5G | EUR 106.51 |
5-Fluoro-UTP |
|||
NU-1115L | Jena Bioscience GmbH | 5 x 10µl | EUR 461.7 |
5-Fluoro-UTP |
|||
NU-1115S | Jena Bioscience GmbH | 10µl | EUR 157.6 |
2-Fluoro-ATP |
|||
NU-145L | Jena Bioscience GmbH | 5 x 10µl | EUR 604.6 |
2-Fluoro-ATP |
|||
NU-145S | Jena Bioscience GmbH | 10µl | EUR 208.5 |
5-Fluoro-UMP |
|||
NU-146L | Jena Bioscience GmbH | 5 x 50µl | EUR 439.5 |
5-Fluoro-UMP |
|||
NU-146S | Jena Bioscience GmbH | 50µl | EUR 150.1 |
9-FLUORENOL |
|||
T8633-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: 9-FLUORENOL |
9-FLUORENOL |
|||
T8633-1g | TargetMol Chemicals | 1g | Ask for price |
Description: 9-FLUORENOL |
9-FLUORENOL |
|||
T8633-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: 9-FLUORENOL |
9-FLUORENOL |
|||
T8633-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: 9-FLUORENOL |
9-FLUORENOL |
|||
T8633-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: 9-FLUORENOL |
2-Fluoro-ADP |
|||
T29348-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: 2-Fluoro-ADP |
2-Fluoro-ADP |
|||
T29348-1g | TargetMol Chemicals | 1g | Ask for price |
Description: 2-Fluoro-ADP |
2-Fluoro-ADP |
|||
T29348-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: 2-Fluoro-ADP |
2-Fluoro-ADP |
|||
T29348-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: 2-Fluoro-ADP |
2-Fluoro-ADP |
|||
T29348-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: 2-Fluoro-ADP |
5-Fluoro-AMB |
|||
F587305 | Toronto Research Chemicals | 100mg | EUR 1800 |
Description: 1801552-03-3 |
4F2LC Antibody |
|||
39274-100ul | SAB | 100ul | EUR 468 |
Decane, 1-fluoro- |
|||
581786 | MedKoo Biosciences | 1.0g | EUR 310 |
9-Fluorenone |
|||
F01650 | Pfaltz & Bauer | 25G | EUR 126.48 |
5-Fluoro-dUMP |
|||
NU-153L | Jena Bioscience GmbH | 5 x 50µl | EUR 439.5 |
5-Fluoro-dUMP |
|||
NU-153S | Jena Bioscience GmbH | 50µl | EUR 150.1 |
5-Fluoro-dUTP |
|||
NU-154L | Jena Bioscience GmbH | 5 x 20µl | EUR 478.9 |
5-Fluoro-dUTP |
|||
NU-154S | Jena Bioscience GmbH | 20µl | EUR 150.1 |
Decane, 1-fluoro- |
|||
T21116-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Decane, 1-fluoro- |
Decane, 1-fluoro- |
|||
T21116-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Decane, 1-fluoro- |
Decane, 1-fluoro- |
|||
T21116-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Decane, 1-fluoro- |
Decane, 1-fluoro- |
|||
T21116-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Decane, 1-fluoro- |
Decane, 1-fluoro- |
|||
T21116-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Decane, 1-fluoro- |
9-Fluorenone |
|||
F462780 | Toronto Research Chemicals | 250g | EUR 173 |
Description: 486-25-9 |
5-Fluoro ADBICA |
|||
F587255 | Toronto Research Chemicals | 100mg | EUR 4500 |
Description: 1801338-27-1 |
5-Fluoro Isatin |
|||
F592000 | Toronto Research Chemicals | 10g | EUR 58 |
5-Fluoro Uracil |
|||
F596000 | Toronto Research Chemicals | 100g | EUR 138 |
Description: 51-21-8 |
5-Fluoro SDB-005 |
|||
F596270 | Toronto Research Chemicals | 25mg | EUR 1200 |
(4-Fluoro-1-naphthalenyl)[1-(5-fluoropentyl)-1H-indol-3-yl]methanone |
|||
F594460 | Toronto Research Chemicals | 50mg | EUR 1800 |
Description: 1391485-39-4 |
pCDNA3.1-FLAG-TR4 |
|||
PVT14611 | Lifescience Market | 2 ug | EUR 594 |
τ-Fluvalinate |
|||
T35419-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: τ-Fluvalinate |
τ-Fluvalinate |
|||
T35419-1g | TargetMol Chemicals | 1g | Ask for price |
Description: τ-Fluvalinate |
τ-Fluvalinate |
|||
T35419-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: τ-Fluvalinate |
τ-Fluvalinate |
|||
T35419-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: τ-Fluvalinate |
τ-Fluvalinate |
|||
T35419-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: τ-Fluvalinate |
2-Fluoro Viminol |
|||
F468230 | Toronto Research Chemicals | 100mg | EUR 3000 |
Description: 63880-43-3 |
4-Fluoro U-47931E |
|||
F479310 | Toronto Research Chemicals | 500mg | EUR 800 |
Description: 67579-18-4 |
5-Fluoroindan |
|||
F588415 | Toronto Research Chemicals | 1g | EUR 800 |
Description: 37530-82-8 |
5-Fluoro Uridine |
|||
F596500 | Toronto Research Chemicals | 100mg | EUR 126 |
Description: 316-46-1 |
Pyrazine, 2-fluoro- |
|||
20-abx182629 | Abbexa |
|
|
4-Fluoroindole |
|||
20-abx183597 | Abbexa |
|
|
5-Fluorouracil |
|||
20-abx183733 | Abbexa |
|
|
2-Fluorophenol |
|||
20-abx185738 | Abbexa |
|
|
5-Fluorouracil |
|||
B1519-1G | Biovision | each | EUR 130.8 |
5-Fluorouracil |
|||
B1519-5G | Biovision | each | EUR 248.4 |
5-Fluorouracil |
|||
FD0080 | Bio Basic | 5g | EUR 75.66 |
5-Fluorouracil |
|||
F034-1G | TOKU-E | 1 g | EUR 67.2 |
5-Fluorouracil |
|||
F034-5G | TOKU-E | 5 g | EUR 115.2 |
5-Fluoroindole |
|||
GK0555-1G | Glentham Life Sciences | 1 g | EUR 64.8 |
4-Fluorophenol |
|||
GK2089-25G | Glentham Life Sciences | 25 g | EUR 57.6 |
5-Fluoroisatin |
|||
GK4345-25G | Glentham Life Sciences | 25 g | EUR 132 |
5-Fluoroisatin |
|||
GK4345-5G | Glentham Life Sciences | 5 g | EUR 74.4 |
7-Fluoroisatin |
|||
GX5733-5G | Glentham Life Sciences | 5 g | EUR 103.2 |
5-Fluorouracil |
|||
HY-90006 | MedChemExpress | 1g | EUR 142.8 |
5-Fluorouracil |
|||
GP6168-100G | Glentham Life Sciences | 100 g | EUR 250.8 |
5-Fluorouracil |
|||
GP6168-25G | Glentham Life Sciences | 25 g | EUR 122.4 |
5-Fluorouracil |
|||
GP6168-5G | Glentham Life Sciences | 5 g | EUR 64.8 |
pCDNA3.1-FLAG-PSPH |
|||
PVT14713 | Lifescience Market | 2 ug | EUR 594 |
5-Fluorouracil |
|||
16220-01 | NACALAI TESQUE | 1G | EUR 22.4 |
5-Fluorouracil |
|||
16220-14 | NACALAI TESQUE | 5G | EUR 33.6 |
3'-(6-Fluorescein) CPG *1000 Ã…* |
|||
6014-1g | AAT Bioquest | 1 g | EUR 446 |
Description: There are several ways of labeling an oligonucleotide with fluorescein. |
5-Fluorouracil |
|||
GP6168-100 | Glentham Life Sciences | 100 | EUR 177.9 |
5-Fluorouracil |
|||
GP6168-25 | Glentham Life Sciences | 25 | EUR 71.1 |
5-Fluorouracil |
|||
GP6168-5 | Glentham Life Sciences | 5 | EUR 23.8 |
5-Fluoroindole |
|||
GK0555-1 | Glentham Life Sciences | 1 | EUR 23.8 |
4-Fluorophenol |
|||
GK2089-25 | Glentham Life Sciences | 25 | EUR 18.2 |
5-Fluoroisatin |
|||
GK4345-25 | Glentham Life Sciences | 25 | EUR 79.1 |
5-Fluoroisatin |
|||
GK4345-5 | Glentham Life Sciences | 5 | EUR 31.7 |
1-Fluorobutane 98% |
|||
F02790 | Pfaltz & Bauer | 10G | EUR 968.15 |
1-Fluorodecane 95% |
|||
F03040 | Pfaltz & Bauer | 1G | EUR 191.31 |
1-Fluorohexane 99% |
|||
F03210 | Pfaltz & Bauer | 1G | EUR 146.97 |
5-Fluoroindole |
|||
F03220 | Pfaltz & Bauer | 1G | EUR 194 |
5-Fluorouracil 98% |
|||
F04860 | Pfaltz & Bauer | 25G | EUR 162.6 |
2-Fluoro-ara-ATP |
|||
NU-10703-10 | Jena Bioscience GmbH | 10µmol | EUR 540.1 |
7-Fluoroisatin |
|||
GX5733-5 | Glentham Life Sciences | 5 | EUR 55.4 |
2-Fluorophenol |
|||
S-2050 | Scientific Laboratory Supplies | 1ML | EUR 224.4 |
5-Fluorouracil |
|||
40690008-1 | Bio-WORLD | 5 g | EUR 114.99 |
5-Fluorouracil |
|||
40690008-2 | Bio-WORLD | 10 g | EUR 181.65 |
5-Fluorouracil |
|||
40690008-3 | Bio-WORLD | 25 g | EUR 317.71 |
5-Fluorouracil |
|||
40690008-4 | Bio-WORLD | 1 g | EUR 43.81 |
5-Fluorouracil |
|||
T0984-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: 5-Fluorouracil |
5-Fluorouracil |
|||
T0984-1g | TargetMol Chemicals | 1g | Ask for price |
Description: 5-Fluorouracil |
5-Fluorouracil |
|||
T0984-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: 5-Fluorouracil |
5-Fluorouracil |
|||
T0984-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: 5-Fluorouracil |
5-Fluorouracil |
|||
T0984-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: 5-Fluorouracil |
One Health refers to the collaborative efforts of multiple disciplines working locally, nationally and globally to attain optimal health for people, animals and our environment.
The One Health approach is increasingly popular in the context of growing threats from emerging zoonoses, antimicrobial resistance and climate change.
The Food and Agriculture Organization of the United Nations, World Organisation for Animal Health and World Health Organization have been working together in the wake of the avian influenza crisis in the Asia-Pacific region to provide strong leadership to endorse the One Health concept and promote interagency and intersectoral collaboration.
The programme on highly pathogenic emerging diseases in Asia (2009-2014) led to the establishment of a regional tripartite coordination mechanism in the Asia-Pacific region to support collaboration between the animal and human health sectors. The remit of this mechanism has expanded to include other priority One Health challenges, such as antimicrobial resistance and food safety.
The mechanism has helped to organize eight Asia-Pacific workshops on multisectoral collaboration for the prevention and control of zoonoses since 2010, facilitating advocacy and operationalization of One Health at regional and country levels.
The tripartite group and international partners have developed several One Health tools, which are useful for operationalization of One Health at the country level. Member States are encouraged to develop a One Health strategic framework taking into account the country’s context and priorities.